SLNOSoleno Therapeutics Inc
SLNO
Soleno Therapeutics Inc8,259
Mkt Cap
$2.72BVolume
1.2M52W High
$90.3252W Low
$29.43PE Ratio
236.65SLNO Fundamentals
Price
$52.75Prev Close
$52.72Open
$52.7450D MA
$41.58Beta
0.85Avg. Volume
1.66MEPS (Annual)
$0.3909P/B
6.13Rev/Employee
$1.05M$2,172.50
SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman
SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman SLNO 8-DAY DEADLINE ALERT...
PR Newswire·3h ago
SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, April 27, 2026 NEW YORK, April 27, 2026 /PRNewswire/ -- Why:Rosen...
PR Newswire·7h ago
SLNO Deadline: Rosen Law Firm Urges Soleno Therapeutics, Inc. (NASDAQ: SLNO) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26...
Business Wire·10h ago
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Soleno Therapeutics...
PR Newswire·3d ago
Peregrine Capital Management LLC Purchases 26,559 Shares of Soleno Therapeutics, Inc. $SLNO
Peregrine Capital Management LLC boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 28.6% in the 4th quarter, according to its most recent filing with the...
MarketBeat·4d ago
INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman
INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with...
PR Newswire·4d ago
Are WSR, SLNO, OMEX, AVNS Obtaining Fair Deals for their Shareholders?
Are WSR, SLNO, OMEX, AVNS Obtaining Fair Deals for their Shareholders? Are WSR, SLNO, OMEX, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 23, 2026 Insiders may stand...
PR Newswire·4d ago
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: SueWallSt
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: SueWallSt SLNO...
PR Newswire·5d ago
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Hiding Post-Launch Safety Crisis: Levi & Korsinsky
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Hiding Post-Launch Safety Crisis: Levi & Korsinsky SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May...
PR Newswire·6d ago
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno...
PR Newswire·6d ago
<
1
2
...
>